Dietary Phenylalanine and Brain Function

Regional Transport of Phenylalanine and Other Neutral Amino Acids Across the Blood-Brain Barrier

Pages 63-67

Hawkins, Richard A. (et al.)

Dual Role of Transport Competition in Amino Acid Deprivation of the Central Nervous System by Hyperphenylalaninemia

Pages 68-78

Christensen, Halvor N. (et al.)

An In Vivo Study of Dopamine Release in Striatum: The Effects of Phenylalanine

Pages 81-86

During, Matthew J. (et al.)

Effects of Aspartame Ingestion on Large Neutral Amino Acids and Monoamine Neurotransmitters in the Central Nervous System

Pages 87-94

Fernstrom, John D.

Aspartame, Phenylalanine, and Seizures in Experimental Animals

Pages 95-103

Pinto, Judith M. B. (et al.)

Behavioral and Neurological Effects of Aspartame

Pages 104-110

Tilson, Hugh A. (et al.)

Role of Monoamines in Seizure Predisposition in the Genetically Epilepsy-Prone Rat

Pages 111-121

Jobe, Phillip C. (et al.)

Aspartame Administration Decreases the Entry of α-Methyldopa into the Brain of Rats

Pages 122-126

Maher, Timothy J. (et al.)

The Effect of Aspartame on 50% Convulsion Doses of Lidocaine

Pages 127-130

Kim, K. C. (et al.)

Studies on the Susceptibility to Convulsions in Animals Receiving Abuse Doses of Aspartame

Pages 131-143

Garattini, Silvio (et al.)

General Discussion: Calculation of the Aspartame Dose for Rodents that Produces Neurochemical Effects Comparable to Those Occurring in People

Pages 144-148

Wurtman, Richard J. (et al.)

Monoamines and Seizures in Humans

Pages 151-158

Schomer, Donald L.

The Possible Role of Aspartame in Seizure Induction

Pages 159-162

Walton, Ralph G.

Effects of Aspartame on Seizures in Children

Pages 163-168

Shaywitz, Bennett A. (et al.)

Aspartame and Human Behavior: Cognitive and Behavioral Observations

Pages 169-178

Spiers, Paul (et al.)

Effects of High Plasma Phenylalanine Concentration in Older Early-Treated PKU Patients: Performance, Neurotransmitter Synthesis, and EEG Mean Power Frequency

Pages 179-186

Krause, Wilma L. (et al.)

Changes in Physiological Concentrations of Blood Phenylalanine Produce Changes in Sensitive Parameters of Human Brain Function

Pages 187-195

Elsas, Louis J., II (et al.)

The Effects of Aspartame on Human Mood, Performance, and Plasma Amino Acid Levels

Pages 196-200

Lieberman, Harris R. (et al.)

Aspartame and Behavior in Children

Pages 201-206

Wolraich, Mark L.

Responses to Carbohydrate Consumption Among Insulin-Dependent Diabetics

Pages 207-210

Spring, Bonnie (et al.)

Epidemiology and Natural History of Phenylketonuria and Other Hyperphenylalaninemias

Pages 213-227

Güttler, Flemming

Reconsidering the Genetics of Phenylketonuria: Evidence from Molecular Genetics

Pages 228-237

Ledley, Fred D. (et al.)

Effect of Phenylalanine on Brain Maturation: Implications for the Treatment of Patients with Phenylketonuria

Pages 238-243

Hommes, Frits A. (et al.)

Patterns of Phenylalanine Metabolites, Vitamin B6 Status, and Learning Disabilities in Phenylketonuria Children: Modeling for Diet Criteria

Pages 244-248

Prince, Annie

The Neurotoxic Metabolite of Phenylalanine in Phenylketonuria

Pages 249-253

Loo, Y. H. (et al.)

Increased Vigilance and Dopamine Synthesis Effected by Large Doses of Tyrosine in Phenylketonuria

Pages 254-260

Lou, Hans C.

Effect of Dietary Tryptophan Supplement on Neurotransmitter Metabolism in Phenylketonuria

Pages 261-264

Nielsen, Jytte Bieber

Effect of Aspartame in Diabetic Rats

Pages 265-268

Sardesai, V. M. (et al.)

Maternal Phenylketonuria Collaborative Study (MPKUCS): USA and Canada

Pages 269-271

Koch, R. (et al.)

Effects of Aspartame on Appetite and Food Intake

Pages 275-295

Blundell, John E. (et al.)

Effects of Phenylalanine and Aspartame on Mealtime Food Intake and Behavior in Adult Males

Pages 296-299

Leiter, Lawrence A. (et al.)

Aspartame and Headache

Pages 303-312

Johns, Donald R.

The Effect of Aspartame Consumption on Migraine Headache: Preliminary Results

Pages 313-316

Koehler, Shirley M.

Monitoring of Adverse Reactions to Aspartame Reported to the U.S. Food and Drug Administration

Pages 317-337

Tollefson, Linda (et al.)

Facts and Myths Related to the Use and Regulation of Phenylalanine and Other Amino Acids

Pages 341-347

Young, Simon N.

Perspectives of the Health-Food Industry on the Use of Pure Phenylalanine

Pages 348-352

Yingling, Gary L.

Regulation of Food Additives with Neurotoxic Potential

Pages 355-360

Hattan, David G.

Regulatory Aspects of the Use of Low-Calorie Intensive Sweeteners

Pages 361-364

Eisenberg, Aharon

Resources for Inferential Estimates of Aspartame Intake in the United States

Pages 365-372

Heybach, John P. (et al.)

Neurological, Psychiatric, and Behavioral Reactions to Aspartame in 505 Aspartame Reactors

Pages 373-376

Roberts, H. J.

Public Policy and Food Additives: The NutraSweet Controversy

Pages 377-380

Wagoner, James

The Regulatory Process and Aspartame: Why the Controversy?

Pages 381-385

Phelps, James R.

Conference on Dietary Phenylalanine and Brain Function, May 8–10, 1987, Washington, DC

Pages 389-391

Wurtman, Richard J.